Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping Mounjaro does not have to mean the weight comes straight back, but the risk is real and the research is clear: without a plan, many people do regain. Weight regain after discontinuing tirzepatide is documented, and understanding why it happens is the first step to avoiding it. Mounjaro (tirzepatide) is a prescription-only medicine requiring clinical assessment, so any decision to stop or taper should involve the prescriber who oversees your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception worth tackling first. Many people assume that if weight returns when they stop Mounjaro, the treatment did not work. The truth is the opposite. Tirzepatide actively suppresses appetite by acting on GIP and GLP-1 receptors in a way that lowers hunger signals. When you stop, those signals return. That is not failure, it is physiology.
Obesity is a chronic condition. The NHS describes obesity as a complex health condition shaped by hormones, genetics and environment, not simply what someone eats. Mounjaro addresses several of those biological drivers while you take it. It does not rewire them permanently. So the question is not "why did the weight come back?" but "what can I put in place before I stop so that it is less likely to?"
That shift in framing matters practically. People who spend their time on treatment building new habits (portions, movement, sleep, protein intake) tend to hold more of their losses than those who rely entirely on the appetite suppression without changing anything else. The medicine creates the window; what you do inside that window determines how much carries forward.
Tirzepatide slows gastric emptying and amplifies fullness signals. Those effects reverse within days to weeks of stopping. Hunger typically returns more forcefully than before treatment because the brain had adapted to a lower appetite baseline, and the sudden absence of the suppression can feel sharp.
Evidence from the broader GLP-1 class supports this. Trial data cited in NICE's appraisal of tirzepatide (TA1026) acknowledges that continuing treatment is associated with maintaining loss, and that stopping is a factor in regain. Some participants in discontinuation extension arms of major trials regained a substantial proportion of lost weight within a year of stopping, even when they had lost significantly during active treatment.
This is not an argument against stopping. There are many clinically valid reasons to come off Mounjaro: planned pregnancy, surgery, a period away from injectable treatment, or simply a decision made with your prescriber that the time is right. The point is to stop with a plan rather than abruptly.
If you are thinking through the timing of stopping (whether that is around a holiday, a life event, or simply weighing up payday and monthly costs) our page on when to come off Mounjaro covers the clinical considerations in detail.
There is no trick that fully replaces the medicine's appetite effect. But several things are consistently associated with better outcomes after stopping, and they are all within reach.
Protein at every meal. Protein takes longer to digest and blunts hunger more effectively than refined carbohydrates. During treatment your appetite is suppressed enough that you may under-eat protein without noticing. Before stopping, make sure protein is a fixture, not an afterthought. Aim for it at breakfast especially, since that meal sets the tone for hunger through the day.
Strength activity alongside cardio. Muscle tissue burns more energy at rest than fat. People who include resistance exercise during and after GLP-1 treatment retain more of their lean mass and find weight management easier afterwards. This does not mean gym membership, body-weight exercises, walking with load, or a simple routine at home all count.
Gradual rather than abrupt stopping. Talk to your prescriber about tapering. Reducing the dose in steps before stopping completely can blunt the sharpness of appetite returning. There is no one-size protocol, which is exactly why this decision belongs in a consultation. For broader background on what a structured stop looks like, the page on how to come off Mounjaro walks through the process.
Monitoring your weight honestly, without anxiety. A small fluctuation in the weeks after stopping is normal and mostly reflects water and gut content, not fat. Check in with yourself weekly, not daily. If the trend is consistently upward over six to eight weeks, that is the moment to speak to your prescriber, not a reason to panic, but a signal worth acting on.
Some people also find the stopping and restarting question relevant here: returning to Mounjaro after a planned break is a legitimate clinical path for some people, subject to review.
Coming off any prescription medicine is a clinical decision, and Mounjaro is no different. Before your final dose, there are specific things worth raising with your prescriber: your current weight trajectory, whether your weight-related conditions have improved, your lifestyle plan post-treatment, and whether a gradual step-down or immediate stop is more appropriate for your situation.
It is also worth asking about the timing of your last dose relative to any upcoming events. If you are considering a break rather than permanent stopping, the page on taking a short break from Mounjaro covers what to expect.
The NHS tirzepatide patient information is a useful reference for what to expect in the weeks after stopping, including which effects resolve quickly and which may take longer. For a broader look at what Mounjaro does and who it suits before any stopping decision, our Mounjaro treatment guide is a good starting point.
If you are weighing up whether private treatment is affordable enough to continue, our page on Mounjaro costs in the UK gives honest context on pricing across providers.
If you have questions about your treatment or want to discuss your situation with a clinician who will look at your individual picture, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.